Muttaqin, F. Z., H. Ramadhanty, H. N. Muhammad, and I. Musfiroh. “Inhibiting Adenosine A2A Receptors As a Treatment for Parkinson’s Disease”. SIGn Journal of Pharmacy, Vol. 1, no. 1, May 2022, pp. 1-5, doi:10.37276/sjp.v1i1.140.